// May 03, 2018
Solutions to help ensure biopharmaceutical quality
By the year 2020, biopharmaceuticals are estimated to account for 50% of the most successful phar
By the year 2020, biopharmaceuticals are estimated to account for 50% of the most successful phar
Highly complex biologics such as proteins, monoclonal antibodies, and cell and gene therapies inc
Desmond Hunt, Ph.D., USP’s Senior Scientific Liaison, provides insight into packaging
In 2015 and 2016, USP launched a series of “roundtable” events designed to engage industry in dis